discovery of glp-1 receptor assay: drug in the metabolic field GLP-1-based therapies for type 2

The inventor Guilford filed a provisional patent application Ser

it often depends upon a high index of suspicion engendered by the finding of failure to thrive and Fanconi syndrome

Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: a head-to-head meta-analysis

Nanotechnology is one of the emerging multidisciplinary areas dealing with physics, biochemistry, material science, chemistry, biology, medicine, informatics, and engineering [6, 7]

We provide Ashwagandha as KSM-66, the most scientifically supported form, containing a high concentration of active compounds from the root-only

Tekin, D., Yavuzer, S., Tekin, M., Akar, N